The global Interventional Lung Disease Market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of lung diseases and rising awareness about the benefits of interventional lung disease procedures. The market is also driven by factors such as increasing number of patients with chronic obstructive pulmonary disease (COPD) and asthma, which are leading to increased demand for interventional lung disease procedures.
The global Interventional Lung Disease Market can be segmented on the basis of type, application, and region. On the basis of type, it can be segmented into bronchoscopes, respiratory endotherapy devices, ENB systems and pleuroscopes. On the basis of application it can be segmented into hospital emergency center clinic and others (emergency room). On the basis on region it can be segmented into North America Latin America Europe Asia Pacific Middle East & Africa.
Some Of The Growth Factors Of This Market:
- The number of people with chronic obstructive pulmonary disease (COPD) is expected to increase by more than 50% in the next 20 years.
- The number of people with asthma is expected to increase by more than 50% in the next 20 years.
- The number of people with cystic fibrosis is expected to increase by more than 50% in the next 20 years.
- Lung cancer rates are increasing, and lung cancer will be the leading cause of cancer-related deaths worldwide by 2030.
- Smoking rates are declining but still high.
Industry Growth Insights published a new data on “Interventional Lung Disease Market”. The research report is titled “Interventional Lung Disease Market research by Types (Bronchoscopes, Respiratory Endotherapy Devices, ENB Systems, Pleuroscopes, Other), By Applications (Hospital, Emergency Center, Clinic), By Players/Companies Boston Scientific, Olympus, FUJIFILM, Becton, Dickinson and Company, Smiths Group, Cook Medical, Vygon, PENTAX Medical, Clarus Medical, HUGER Medical Instrument, Richard Wolf, Karl Storz, Taewoong Medical, ELLA - CS”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Interventional Lung Disease Market Research Report
By Type
Bronchoscopes, Respiratory Endotherapy Devices, ENB Systems, Pleuroscopes, Other
By Application
Hospital, Emergency Center, Clinic
By Companies
Boston Scientific, Olympus, FUJIFILM, Becton, Dickinson and Company, Smiths Group, Cook Medical, Vygon, PENTAX Medical, Clarus Medical, HUGER Medical Instrument, Richard Wolf, Karl Storz, Taewoong Medical, ELLA - CS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Interventional Lung Disease Market Report Segments:
The global Interventional Lung Disease market is segmented on the basis of:
Types
Bronchoscopes, Respiratory Endotherapy Devices, ENB Systems, Pleuroscopes, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Emergency Center, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Olympus
- FUJIFILM
- Becton, Dickinson and Company
- Smiths Group
- Cook Medical
- Vygon
- PENTAX Medical
- Clarus Medical
- HUGER Medical Instrument
- Richard Wolf
- Karl Storz
- Taewoong Medical
- ELLA - CS
Highlights of The Interventional Lung Disease Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bronchoscopes
- Respiratory Endotherapy Devices
- ENB Systems
- Pleuroscopes
- Other
- By Application:
- Hospital
- Emergency Center
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Interventional Lung Disease Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Interventional lung disease is a type of lung cancer treatment that uses medical devices and techniques to help the patient breathe better.
Some of the major companies in the interventional lung disease market are Boston Scientific, Olympus, FUJIFILM, Becton, Dickinson and Company, Smiths Group, Cook Medical, Vygon, PENTAX Medical, Clarus Medical, HUGER Medical Instrument, Richard Wolf, Karl Storz, Taewoong Medical, ELLA - CS.
The interventional lung disease market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Interventional Lung Disease Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Interventional Lung Disease Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Interventional Lung Disease Market - Supply Chain
4.5. Global Interventional Lung Disease Market Forecast
4.5.1. Interventional Lung Disease Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Interventional Lung Disease Market Size (000 Units) and Y-o-Y Growth
4.5.3. Interventional Lung Disease Market Absolute $ Opportunity
5. Global Interventional Lung Disease Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Interventional Lung Disease Market Size and Volume Forecast by Type
5.3.1. Bronchoscopes
5.3.2. Respiratory Endotherapy Devices
5.3.3. ENB Systems
5.3.4. Pleuroscopes
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Interventional Lung Disease Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Interventional Lung Disease Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Emergency Center
6.3.3. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Interventional Lung Disease Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Interventional Lung Disease Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Interventional Lung Disease Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Interventional Lung Disease Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Interventional Lung Disease Demand Share Forecast, 2019-2026
9. North America Interventional Lung Disease Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Interventional Lung Disease Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Interventional Lung Disease Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Emergency Center
9.4.3. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Interventional Lung Disease Market Size and Volume Forecast by Type
9.7.1. Bronchoscopes
9.7.2. Respiratory Endotherapy Devices
9.7.3. ENB Systems
9.7.4. Pleuroscopes
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Interventional Lung Disease Demand Share Forecast, 2019-2026
10. Latin America Interventional Lung Disease Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Interventional Lung Disease Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Interventional Lung Disease Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Emergency Center
10.4.3. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Interventional Lung Disease Market Size and Volume Forecast by Type
10.7.1. Bronchoscopes
10.7.2. Respiratory Endotherapy Devices
10.7.3. ENB Systems
10.7.4. Pleuroscopes
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Interventional Lung Disease Demand Share Forecast, 2019-2026
11. Europe Interventional Lung Disease Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Interventional Lung Disease Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Interventional Lung Disease Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Emergency Center
11.4.3. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Interventional Lung Disease Market Size and Volume Forecast by Type
11.7.1. Bronchoscopes
11.7.2. Respiratory Endotherapy Devices
11.7.3. ENB Systems
11.7.4. Pleuroscopes
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Interventional Lung Disease Demand Share, 2019-2026
12. Asia Pacific Interventional Lung Disease Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Interventional Lung Disease Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Interventional Lung Disease Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Emergency Center
12.4.3. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Interventional Lung Disease Market Size and Volume Forecast by Type
12.7.1. Bronchoscopes
12.7.2. Respiratory Endotherapy Devices
12.7.3. ENB Systems
12.7.4. Pleuroscopes
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Interventional Lung Disease Demand Share, 2019-2026
13. Middle East & Africa Interventional Lung Disease Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Interventional Lung Disease Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Interventional Lung Disease Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Emergency Center
13.4.3. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Interventional Lung Disease Market Size and Volume Forecast by Type
13.7.1. Bronchoscopes
13.7.2. Respiratory Endotherapy Devices
13.7.3. ENB Systems
13.7.4. Pleuroscopes
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Interventional Lung Disease Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Interventional Lung Disease Market: Market Share Analysis
14.2. Interventional Lung Disease Distributors and Customers
14.3. Interventional Lung Disease Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boston Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Olympus
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. FUJIFILM
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Becton, Dickinson and Company
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Smiths Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cook Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Vygon
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. PENTAX Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Clarus Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. HUGER Medical Instrument
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Richard Wolf
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Karl Storz
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Taewoong Medical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. ELLA - CS
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
